Surgical Changes and Recommendations during COVID 19: NCCN Melanoma Guidelines Explained скачать в хорошем качестве

Surgical Changes and Recommendations during COVID 19: NCCN Melanoma Guidelines Explained

From the Clinic to the Living Room: Conversations with Melissa Wilson, PA-C, MPAS SPECIAL GUEST: Jeffrey M. Farma, MD, FACS Co-Director, Melanoma and Skin Cancer Program Chief, Division of General Surgery Professor, Department of Surgical Oncology Program Director, Complex General Surgical Oncology Fellowship Fox Chase Cancer Center Jeffrey Farma, MD, has built a career as a leading clinical expert in complex surgical oncology, as well as a clinical researcher and educator. He has served as the Society of Surgical Oncology (SSO) fellowship program director since 2013 and has a national and growing international reputation, having authored or co-authored more than 150 peer reviewed publications, chapters, and abstracts. He specializes in treating colorectal cancer, melanoma, sarcoma, and minimally invasive and robotic surgery. Dr. Farma serves in several leadership positions at Fox Chase and within the oncology field. He is co-director of the Fox Chase Melanoma and Skin Cancer program, a member of the National Comprehensive Cancer Network (NCCN) panel on non-melanoma skin cancer, and an award-winning advocate and fundraiser for area sarcoma, colorectal cancer, and skin cancer organizations. Dr. Farma has been an integral part of Fox Chase for more than two decades, first as a medical student, then as a resident. He returned to Fox Chase as an attending surgeon after completing his residency in general surgery at Temple University Hospital and surgical oncology fellowships at Moffitt Cancer Center in Tampa and the National Cancer Institute in Bethesda, Maryland.